Stent Retrievers Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$2500
Buy Report Download FREE Resources

Published: October 18, 2024 Report Code: GDME1867EPD-ST

Select Item

Stent Retrievers Pipeline Market Report Overview

Stent retrievers are deployed by a catheter that is threaded through the clot. Once the stent is fully deployed, the stent is retrieved with the clot attached. The stent retrievers pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials.

Key Territories ·       The United States

·       Europe

·       Singapore

·       Israel

·       Japan
Key Regulatory Paths ·       510(k)

·       HSA

·       CE

·       Ninsho
Leading Companies ·       Amnis Therapeutics Ltd

·       Biomedical Solutions Inc

·       Capital Medical University

·       HeMo Bioengineering Ltd

·       Insera Therapeutics LLC
Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Stent Retrievers Pipeline Market Segmentation by Territories

 The key territories associated with the stent retrievers pipeline market are Europe, the United States, Singapore, Japan, and Israel. As of October 2024, the US had the highest number of stent retrievers pipeline products.

Stent Retrievers Pipeline Market Analysis by Territories, 2024 (%)

Stent Retrievers Pipeline Market Analysis by Territories, 2024 (%)

Buy the Full Report for More Territory Insights into the Stent Retrievers Pipeline Market

Download a Free Report Sample

Stent Retrievers Pipeline Market Segmentation by Regulatory Paths

A few of the key regulatory paths in the stent retrievers pipeline products market are CE, Ninsho, HSA, and 510(k). As of October 2024, 510(k) was the most followed pathway for pipeline products in the stent retrievers market.

Stent Retrievers Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Stent Retrievers Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Buy the Full Report for More Regulatory Path Insights into the Stent Retrievers Pipeline Market

Download a Free Report Sample

Stent Retrievers Pipeline Market – Competitive Landscape

A few of the key companies associated with the stent retrievers pipeline market are Amnis Therapeutics Ltd, Biomedical Solutions Inc, Capital Medical University, HeMo Bioengineering Ltd, and Insera Therapeutics LLC among others.

Amnis Therapeutics Ltd: Amnis Therapeutics Ltd (Amnis Therapeutics), formerly ITGI Medical Ltd, is a bio-medical engineering company that offers research, development, design, manufacture, and commercialization of medical devices for endovascular indications. The company offers Aneugraft Dx and Aneugraft Nx, biologically covered coronary stents, which facilitate immediate blood vessel reconstruction.

Biomedical Solutions Inc: Biomedical Solutions Inc (BSI) is a manufacturer of laboratory equipment. It is headquartered in Stafford, Texas, the US.

Stent Retrievers Pipeline Market Analysis by Companies, As of October 2024
Stent Retrievers Pipeline Market Analysis by Companies, As of October 2024Buy the Full Report for More Company Insights into the Stent Retrievers Pipeline Market
Download a Free Report Sample

Segments Covered in the Report

Stent Retrievers Pipeline Market Territories Outlook (2024)

  • The United States
  • Europe
  • Singapore
  • Israel
  • Japan

Stent Retrievers Pipeline Market Regulatory Paths Outlook (2024)

  • 510(k)
  • NMPA
  • CE
  • Ninsho

Scope

  • Extensive coverage of the stent retrievers under development.

  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details, and other developmental activities.

  • The report reviews the major players involved in the development of stent retrievers and list all their pipeline projects.

  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage.

  • The report provides key clinical trial data of ongoing trials specific to pipeline products

  • Recent developments in the segment / industry.

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.

  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage.

  • Identify and understand important and diverse types of stent retrievers under development.

  • Develop market-entry and market expansion strategies.

  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.

  • In-depth analysis of the product’s current stage of development, territory and estimated launch date.

Amnis Therapeutics Ltd
Biomedical Solutions Inc
Capital Medical University
HeMo Bioengineering Ltd
Insera Therapeutics LLC
Medtronic Plc
MicroPort NeuroScientific Corp
MiVi Neuroscience Inc
Nanjing Kanite Medical Technology Co Ltd
NeuroVasc Technologies Inc
OrbusNeich
Perflow Medical, Ltd.
Shanghai MicroPort Medical Group Co Ltd
SinoMedCare Biotech Co Ltd
Sree Chitra Tirunal Institute for Medical Sciences & Technology
Triticum Medical Ltd.
Vesalio LLC
Zhejiang Kindly Medical Devices Co Ltd
Zylox-Tonbridge Medical Technology Co Ltd

Table of Contents

  • 1 Table of Contents

  • 1.1 List of Tables

  • 1.2 List of Figures

  • 2 Introduction

    • 2.1 Stent Retrievers Overview

  • 3 Products under Development

    • 3.1 Stent Retrievers – Pipeline Products by Stage of Development

    • 3.2 Stent Retrievers – Pipeline Products by Territory

    • 3.3 Stent Retrievers – Pipeline Products by Regulatory Path

    • 3.4 Stent Retrievers – Pipeline Products by Estimated Approval Date

    • 3.5 Stent Retrievers – Ongoing Clinical Trials

  • 4 Stent Retrievers – Pipeline Products under Development by Companies

    • 4.1 Stent Retrievers Companies – Pipeline Products by Stage of Development

    • 4.2 Stent Retrievers – Pipeline Products by Stage of Development

  • 5 Stent Retrievers Companies and Product Overview

    • 5.1 Amnis Therapeutics Ltd Company Overview

      • 5.1.1 Amnis Therapeutics Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.2 Biomedical Solutions Inc Company Overview

      • 5.2.1 Biomedical Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.3 Capital Medical University Company Overview

      • 5.3.1 Capital Medical University Pipeline Products & Ongoing Clinical Trials Overview

    • 5.4 HeMo Bioengineering Ltd Company Overview

      • 5.4.1 HeMo Bioengineering Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.5 Insera Therapeutics LLC Company Overview

      • 5.5.1 Insera Therapeutics LLC Pipeline Products & Ongoing Clinical Trials Overview

    • 5.6 Medtronic Plc Company Overview

      • 5.6.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.7 MicroPort NeuroScientific Corp Company Overview

      • 5.7.1 MicroPort NeuroScientific Corp Pipeline Products & Ongoing Clinical Trials Overview

    • 5.8 MiVi Neuroscience Inc Company Overview

      • 5.8.1 MiVi Neuroscience Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.9 Nanjing Kanite Medical Technology Co Ltd Company Overview

      • 5.9.1 Nanjing Kanite Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.10 NeuroVasc Technologies Inc Company Overview

      • 5.10.1 NeuroVasc Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.11 OrbusNeich Company Overview

      • 5.11.1 OrbusNeich Pipeline Products & Ongoing Clinical Trials Overview

    • 5.12 Perflow Medical, Ltd. Company Overview

      • 5.12.1 Perflow Medical, Ltd. Pipeline Products & Ongoing Clinical Trials Overview

    • 5.13 Shanghai MicroPort Medical Group Co Ltd Company Overview

      • 5.13.1 Shanghai MicroPort Medical Group Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.14 SinoMedCare Biotech Co Ltd Company Overview

      • 5.14.1 SinoMedCare Biotech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.15 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview

      • 5.15.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview

    • 5.16 Triticum Medical Ltd. Company Overview

      • 5.16.1 Triticum Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview

    • 5.17 Vesalio LLC Company Overview

      • 5.17.1 Vesalio LLC Pipeline Products & Ongoing Clinical Trials Overview

    • 5.18 Zhejiang Kindly Medical Devices Co Ltd Company Overview

      • 5.18.1 Zhejiang Kindly Medical Devices Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.19 Zylox-Tonbridge Medical Technology Co Ltd Company Overview

      • 5.19.1 Zylox-Tonbridge Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

  • 6 Stent Retrievers- Recent Developments

    • 6.1 Sep 04, 2024: Rapid Medical Reports No Safety Concerns for Medium Vessel Occlusions in the Interim Safety Analysis of the DISTALS Study with TIGERTRIEVER13

    • 6.2 Aug 26, 2024: Zylox-Tonbridge Reports Strong Interim Financial Results for 2024, Achieving Significant Growth and Profitability

    • 6.3 Jul 10, 2024: Vesalio Introduces Neva Net

      4.0 MM Following International Success of Neva Net

      5.5 MM

    • 6.4 May 14, 2024: Rapid Medical Completes Successful Ischemic Stroke Procedures with the World’s First Robotic Thrombectomy Device

    • 6.5 Feb 05, 2024: Wallabyphenox Boldly Sets New Benchmark in Evidence-Based Medicine with the Prost Trial

    • 6.6 Dec 14, 2023: Rapid Medical receives Japanese approval for revascularisation device

    • 6.7 Nov 16, 2023: Rapid Medical’s TIGERTRIEVER Delivers First-Pass Success in Challenging Ischemic Stroke Patients with ICAD

    • 6.8 Nov 05, 2023: phenox Receives Additional 510(K) Clearance for pREset LITE Thrombectomy Device

  • 7 Appendix

    • 7.1 Methodology

    • 7.2 About GlobalData

    • 7.3 Contact Us

    • 7.4 Disclaimer

Table

Stent Retrievers – Pipeline Products by Stage of Development

Stent Retrievers – Pipeline Products by Territory

Stent Retrievers – Pipeline Products by Regulatory Path

Stent Retrievers – Pipeline Products by Estimated Approval Date

Stent Retrievers – Ongoing Clinical Trials

Stent Retrievers Companies – Pipeline Products by Stage of Development

Stent Retrievers – Pipeline Products by Stage of Development

Amnis Therapeutics Ltd Pipeline Products & Ongoing Clinical Trials Overview

Golden Retriever – Product Status

Golden Retriever – Product Description

Biomedical Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview

Tron Delta – Product Status

Tron Delta – Product Description

Capital Medical University Pipeline Products & Ongoing Clinical Trials Overview

Catfish Stent Retriever – Product Status

Catfish Stent Retriever – Product Description

HeMo Bioengineering Ltd Pipeline Products & Ongoing Clinical Trials Overview

Stent Retriever – Product Status

Stent Retriever – Product Description

Insera Therapeutics LLC Pipeline Products & Ongoing Clinical Trials Overview

Shelter Retriever – Product Status

Shelter Retriever – Product Description

Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview

MindFrame IRIIS System – Product Status

MindFrame IRIIS System – Product Description

MicroPort NeuroScientific Corp Pipeline Products & Ongoing Clinical Trials Overview

Clot Retrieval Device – Product Status

Clot Retrieval Device – Product Description

MiVi Neuroscience Inc Pipeline Products & Ongoing Clinical Trials Overview

DAISe Clot Retrieval System – Product Status

DAISe Clot Retrieval System – Product Description

MiVi Neuroscience Inc – Ongoing Clinical Trials Overview

DAISe Clot Retrieval System – A Feasibility Study for the DAISe EZ Thrombectomy Device – Pacific

Nanjing Kanite Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

Stent Retriever – Stroke – Product Status

Stent Retriever – Stroke – Product Description

NeuroVasc Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview

eNVi-SR – Product Status

eNVi-SR – Product Description

NeuroVasc Technologies Inc – Ongoing Clinical Trials Overview

eNVi-SR – A Chinese Pivotal Randomized Controlled Trial of ENVI-SR Mechanical Thrombectomy System in Patients with Acute Ischemic Stroke

eNVi-SR – A Randomized Controlled Trial of Envi-SR for Endovascular Treatment of Ischemic Stroke: US IDE Clinical Trial

OrbusNeich Pipeline Products & Ongoing Clinical Trials Overview

Neuro Retriver Device – Product Status

Neuro Retriver Device – Product Description

Perflow Medical, Ltd. Pipeline Products & Ongoing Clinical Trials Overview

Stream Dynamic Neuro-Thrombectomy Net – Product Status

Stream Dynamic Neuro-Thrombectomy Net – Product Description

Stream17 Dynamic Neuro-Thrombectomy Net – Product Status

Stream17 Dynamic Neuro-Thrombectomy Net – Product Description

Shanghai MicroPort Medical Group Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

Clot Retriever Device – Product Status

Clot Retriever Device – Product Description

SinoMedCare Biotech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

Clot Retriever Device – Product Status

Clot Retriever Device – Product Description

Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview

Mechanical Clot Retriever – Product Status

Mechanical Clot Retriever – Product Description

Triticum Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview

Clot Retrieval Device – Product Status

Clot Retrieval Device – Product Description

Vesalio LLC Pipeline Products & Ongoing Clinical Trials Overview

NeVa – 3mm – Product Status

NeVa – 3mm – Product Description

NeVa – 6mm – Product Status

NeVa – 6mm – Product Description

NeVa M1 – Product Status

NeVa M1 – Product Description

NeVa M1S – Product Status

NeVa M1S – Product Description

NeVa NET – Product Status

NeVa NET – Product Description

NeVa Neurothrombectomy System – Product Status

NeVa Neurothrombectomy System – Product Description

NeVa T5 – Product Status

NeVa T5 – Product Description

NeVa TV – Product Status

NeVa TV – Product Description

Vesalio LLC – Ongoing Clinical Trials Overview

NeVa Neurothrombectomy System – A Prospective, Open-label, Multi-center, Registry Designed to Assess the Safety, Performance and Efficacy of the NeVa Stent Retriever in the Treatment of Large Vessel Occlusion Strokes

NeVa Neurothrombectomy System – NEVA ONE One-pass Reperfusion with the NeVa Stent-retriever EMEA Registry

NeVa Neurothrombectomy System – Prospective, Open-label, Multi-center Single-arm Trial Designed to Assess the Safety, Performance and Efficacy of the NeVa Stent Retriever in the Treatment of Large Vessel Occlusion Strokes

NeVa Neurothrombectomy System – Prospective, Open-label, Multi-center Single-arm Trial Designed to Assess the Safety, Performance and Efficacy of the NeVa Stent Retriever in the Treatment of Large Vessel Occlusion Strokes

Zhejiang Kindly Medical Devices Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

Clot Retriever Device – Product Status

Clot Retriever Device – Product Description

Zylox-Tonbridge Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

Thrombite Clot Retriever Device – Pulmonary Embolism – Product Status

Thrombite Clot Retriever Device – Pulmonary Embolism – Product Description

Glossary

Figures

Stent Retrievers – Pipeline Products by Stage of Development

Stent Retrievers – Pipeline Products by Territory

Stent Retrievers – Pipeline Products by Regulatory Path

Stent Retrievers – Pipeline Products by Estimated Approval Date

Stent Retrievers – Ongoing Clinical Trials

Frequently asked questions

Stent Retrievers Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies standard reports
Currency USD
$2,500

Can be used by individual purchaser only

Most Popular
$5,000

Can be shared by unlimited users within one corporate location e.g. a regional office

$7,500

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying Download FREE Resources

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Sample Report

Stent Retrievers Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Stent Retrievers reports
Medical Devices
New
Medical Devices M&A Deals H1 2026 - Top Themes: Strategic…
$495 | July 2026
Medical Devices
New
AI-designed Materials: Market Trends and Innovations
$995 | July 2026
Medical Devices
New
Traditional Wound Management Market Size by Segments, Share, Regulatory, Reimbursement,…
$7,500 | June 2026
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Stent Retrievers Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies in real time.

  • Access a live Stent Retrievers Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more